CME
Latest Episodes
From Awareness to Action: What To Do With a Positive OSA Screen?
Host: Anne Marie Morse, DO, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA, and
How to Screen for OSA
Host: Seema Khosla, MD, FCCP, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA, a
Overcoming Hurdles: Effective OSA Screening in Primary Care
Host: Michael E. Yurcheshen, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA
Pre-Operative Vigilance: The Role of OSA Screening in Surgical Safety
Host: Kevin Trice, MD One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA, and you can mak
OSA: Exploring the Impact on Morbidity and Mortality
Host: Alcibiades J. Rodriguez, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of O
Case Time! VTE Prophylaxis Post Hip Replacement
Host: Victor F. Tapson, MD Venous thromboembolism (VTE) morbidity, mortality, and impact on the overall quality of life start with timely diagnosis, appropriate initial treatment, and management. Prevention occurs at a primary and secondary leve
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
Host: Bruce L. Davidson, MD, MPH Host: Victor F. Tapson, MD Venous thromboembolism (VTE) morbidity, mortality, and impact on the overall quality of life start with timely diagnosis, appropriate initial treatment, and management. Prevention o
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Host: Scott Kaatz, DO, MSc, FACP, SFHM Venous thromboembolism (VTE) morbidity, mortality, and impact on the overall quality of life start with timely diagnosis, appropriate initial treatment, and management. Prevention occurs at a primary and se
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
Host: Scott Kaatz, DO, MSc, FACP, SFHM Venous thromboembolism (VTE) morbidity, mortality, and impact on the overall quality of life start with timely diagnosis, appropriate initial treatment, and management. Prevention occurs at a primary and se
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Host: Deborah Siegal, MD, MSc, FRCPC Venous thromboembolism (VTE) morbidity, mortality, and impact on the overall quality of life start with timely diagnosis, appropriate initial treatment, and management. Prevention occurs at a primary and seco
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast